Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MAGENTA THERAPEUTICS, INC.

(MGTA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MAGENTA THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K)

07/27/2021 | 04:57pm EDT

Item 2.02 Results of Operations and Financial Condition.

Pursuant to Form 8-K, Item 2.02 (Results of Operations and Financial Condition), Magenta Therapeutics, Inc. (the "Company") reports that on July 21, 2021, it issued a press release providing a corporate update, including a preliminary estimate of the Company's cash balance as of June 30, 2021; the Company reported that it held over $200 million in cash as of June 30, 2021, and hereby clarifies that this amount includes cash equivalents and marketable securities, in addition to cash. These financial results remain only estimates and are based on information available to management as of the date of this Current Report on Form 8-K and these estimates could change. The Company's actual financial results as of June 30, 2021 are subject to the completion of its financial statements as of and for such period. Complete results as of June 30, 2021 will be included in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021.

The information in this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about MAGENTA THERAPEUTICS, INC.
09/15MAGENTA THERAPEUTICS : Gets FDA Clearance for Leukemia Drug Trial, Plans Phase 1..
MT
09/15Magenta Therapeutics Gets IND Clearance for MGTA-117
DJ
09/15MAGENTA THERAPEUTICS : Announces IND Clearance for MGTA-117 Targeted Conditionin..
BU
09/15Magenta Therapeutics, Inc. Announces That Its Investigational New Drug Applic..
CI
09/09TSCAN THERAPEUTICS : Names Zoran Zdraveski as Chief Legal Officer
MT
08/12NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
08/05MAGENTA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
08/05Magenta Therapeutics, Inc. Reports Earnings Results for the Second Quarter En..
CI
08/05MAGENTA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Chan..
AQ
08/05Magenta Therapeutics, Inc. Announces Board Changes
CI
More news
Analyst Recommendations on MAGENTA THERAPEUTICS, INC.
More recommendations